Eversept Partners, LP Geron Corp Transaction History
Eversept Partners, LP
- $1.29 Billion
- Q3 2025
A detailed history of Eversept Partners, LP transactions in Geron Corp stock. As of the latest transaction made, Eversept Partners, LP holds 12,599,002 shares of GERN stock, worth $14.1 Million. This represents 1.34% of its overall portfolio holdings.
Number of Shares
12,599,002
Previous 7,320,174
72.11%
Holding current value
$14.1 Million
Previous $10.3 Million
67.23%
% of portfolio
1.34%
Previous 1.04%
Shares
2 transactions
Others Institutions Holding GERN
# of Institutions
288Shares Held
502MCall Options Held
643KPut Options Held
276K-
Ra Capital Management, L.P. Boston, MA60.4MShares$67.6 Million1.42% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$52.1 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT41.1MShares$46 Million1.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA34.4MShares$38.6 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$30.5 Million5.93% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $423M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...